IMULIFE
Rooted in cellular immunology, IMULIFE focuses on the science of immune health. Our first products, BiCore and BiJoy, are daily probiotic formulas built around three clearly identified Bifidobacterium strains.
The gut microbiome interacts with the immune system. This connection helps explain why microbiome research is part of our approach to immune health.
Explore the microbiome with NIH
We chose Bifidobacterium because the connection between the gut microbiome and immune responses is central to our approach, and we want a clear research trail for every strain in our formulas. BiCore and BiJoy contain BGN4, AD011 and BORI. Our selection considers:
We focus on specific strains, formulations and findings. Evidence differs between strains; the highlights and full library identify the formulas and populations studied.
A strain is a specific type of microorganism within a species. The codes BGN4, AD011 and BORI tell you which strains are in our formulas and help you find research on each one.
| Strain | BiCore / sachet | BiJoy / sachet |
|---|---|---|
| Bifidobacterium bifidum BGN4 | 30 billion | 10 billion |
| Bifidobacterium animalis subsp. lactis AD011 | 19 billion | 9 billion |
| Bifidobacterium longum subsp. longum BORI | 1 billion | 1 billion |
| Total | 50 billion | 20 billion |
CFU stands for colony-forming units, a measure of live microorganisms. The count tells you how much a formula contains; the strains, dose and relevant research help you understand its potential benefits.
Probiotic products contain live microorganisms. Prebiotic ingredients provide food for certain microorganisms in the gut.
BiCore includes xylo-oligosaccharides, galacto-oligosaccharides and fructo-oligosaccharides. BiJoy includes xylo-oligosaccharides, along with calcium, iron, zinc and vitamin C.
Explore BiCore Whole Bifidobacteria Probiotic for Adults · Explore BiJoy Whole Bifidobacteria Probiotic for Kids
From immune responses and adult gut health to strain identification, these four research directions are drawn from our full library.
Patent research · BGN4
A BGN4 patent explores food-allergy responses, including work in animal models. It is one research direction for understanding how the strain interacts with immune responses.
KR100635354B1
View the research record →Adult study · BGN4
An eight-week randomised trial in 60 adults reported improvements in markers including zonulin and TNF-α. Weight, BMI and body fat percentage showed no significant between-group improvement.
Choi et al., 2026
View the research record →Multi-strain study · BGN4 / BORI / AD011
A study in 63 people with diarrhoea-predominant IBS used these three strains alongside two others and reported improvements in some bowel-habit measures.
Kim et al., 2020
View the research record →Detection patents · BGN4 / BORI
BGN4 and BORI each have patent records for strain-specific detection primers. This research focuses on identifying particular strains, making the identity of a studied strain more precise.
KR101346739B1 · KR101753243B1
View the research record →These records concern individual strains or specific study formulations. Patents, animal models and human studies provide different kinds of evidence and do not directly establish benefits of finished BiCore or BiJoy products.
Explore all patents and studies
26 patent records · 10 clinical studies / cohorts · Study context and source links
BGN4, BORI and AD011 have received FDA “no questions” responses to GRAS notices for specified food uses. GRAS stands for Generally Recognized as Safe. Explore the FDA letters below for the safety information and conditions of use covered by each notice.
